LRA-Genentech Award on Immune Resetting Therapies for Lupus
Helps yr for pilot or mechanistic immune resetting research in lupus co-funded through the LRAGenentech Award on Immune Resetting Therapies for.
The LRA-Genentech Award on Immune Resetting Therapies for Lupus is a co-funded grant program supported by the Lupus Research Alliance (LRA) and Genentech, a leading biopharmaceutical company. The LRA, a New York 501(c)(3) (Federal Tax ID #58-2492929) with over $284 million distributed across 675+ grants, identified immune resetting as a core strategic priority in its 2024–2028 Research Roadmap, wh…
Immune resetting therapies for lupus: one-year pilot projects on novel immune resetting technologies or methodologies, or two-year mechanistic research into current or emerging immune resetting therapies, co-funded with Genentech.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Submit & reportGrant Reporting Requirements: Post-Award Reports and Compliance
Learn what grant reporting requirements cover, how financial and performance reports work, what to track after an award, and how to avoid post-award compliance mistakes.
BudgetGrant Budget Justification: How to Write the Budget Narrative
Learn how to write a grant budget justification, explain R&D costs, avoid weak budget narratives, and connect each cost to your work plan.
More from LRA
All grants from this funder →Lupus Insight Prize
LRA · United States
Provides prize recognizing a specific significant recent lupus research discovery through the Lupus Insight Prize.
Empowering Lupus Research Administrative Supplement
🇺🇸LRA · United States
Backs Supplements for promising trainees from lupus-affected communities working with active LRA/NIH/DoD funded through the Empowering Lupus Research Administrative Supplement.
Global Team Science Award
🇺🇸LRA · United States
Connects interdisciplinary lupus scientists through the Global Team Science Award to study molecular disease variation.
LRA/RRF Empowering Lupus Research Investigator Award
🇺🇸LRA · United States
Supports early-career lupus investigators with the LRA/RRF Empowering Lupus Research Investigator Award as they establish independent careers.
LRA/RRF Empowering Lupus Research Scientist Development Award
🇺🇸LRA · United States
Funds mentored career award for early-stage lupus researchers through the LRA/RRF Empowering Lupus Research Scientist Development Award.
Lupus Innovation Award
🇺🇸LRA · United States
Offers high-risk high-reward approaches to fundamental lupus research challenges through the Lupus Innovation Award.
Similar grants
Browse the directory →
Individual Investigator Research Award
FFB · United States
Funds investigators advancing research on inherited retinal degeneration and dry AMD.
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research
NIH · United States
Funds the development and hard technical validation that turns a working cancer research technology into one other laboratories will actually adopt.
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research
NIH · United States
Funds further development and rigorous technical validation of a cancer research technology that has already cleared basic feasibility.
CFF Clinical Research Award
🇺🇸CFF · United States
Supports investigator-driven clinical studies addressing diagnosis, treatment, and prevention across key medical priorities.
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research
🇺🇸NIH · United States
Funds rigorously validating a transformative, multi-use platform or technology aimed at heart, lung, blood or sleep disease.
CRI Technology Impact Award
CRI · United States
Pays tenure-track researchers up to $600,000 to build unproven cancer immunotherapy technology.